MJH law firm advised SDS Optic in the public offering of shares and in the process of introduction of the SDS Optic shares to trading on the NewConnect market. The scope of work of MJH included also the assistance in preparation of the equity share option plan for the key managers (ESOP).
SDS Optic develops and creates innovative solutions on the borderline of biochemistry, engineering and fibre optic technologies, that can be used in cancer diagnosis and treatment.
The works for SDS Optic are conducted by the team of MJH lawyers consisting of Dr. Krzysztof Haładyj, Paweł Cyganik, Wojciech Grabowski and Justyna Wigier.